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MicroRNA-124 (miR-124) is the most abundant miRNA in the brain. Biogenesis of
miR-124 displays specific temporal and spatial profiles in various cell and tissue types
and affects a broad spectrum of biological functions in the central nervous system
(CNS). Recently, the link between dysregulation of miR-124 and CNS disorders, such
as neurodegeneration, CNS stress, neuroimmune disorders, stroke, and brain tumors,
has become evident. Here, we provide an overview of the specific molecular function of
miR-124 in the CNS and a revealing insight for the therapeutic potential of miR-124 in
the treatment of human CNS diseases.
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Introduction
The discovery of microRNAs (miRNAs) introduced an understanding of the novel type of
regulatory control over gene expression during plant and animal development (Ambros, 2004;
Bartel, 2004). Mature miRNAs are non-coding transcripts of 18–25 nucleotides, which imperfectly
bind to complementary sequences in the 3′-untranslated regions (UTRs) of target mRNAs to
negatively regulate target gene expression. It is predicted that one third of human genes are miRNA
targets (Lewis et al., 2005).
MicroRNA-124 (miR-124) is highly and speciﬁcally expressed in all brain regions except for
the pituitary gland, and at 100 times lower expression in other tissues (Mishima et al., 2007;
Baroukh and Van Obberghen, 2009). It was ﬁrst identiﬁed in mice (Lagos-Quintana et al., 2002),
and mature miR-124 is wholly homologous in mice, rats, and human. miR-124 has been reported
to participate in chronic stress, neurodegeneration, alcohol/cocaine neuroadaptation, synapse
morphology, neurotransmission long-term potentiation, neurodevelopment myeloid cell function,
and hematopoiesis (Soreq and Wolf, 2011). In mammalian neurons, miR-124 suppresses the levels
of 100s of non-neural genes, which contributes to the acquisition and maintenance of neuronal
identity (Lim et al., 2005; Conaco et al., 2006). Furthermore, whenmiR-124 is aberrantly expressed,
it contributes to pathological conditions involving the central nervous system (CNS) system. It
has also been shown to be useful as a diagnostic and prognostic indicator of CNS disorders, such
as brain tumor and stroke. Here we review the role and potential therapy of miR-124 in CNS
development and disorders.
miR-124 in CNS Development
Central nervous system development refers to the processes that generate, shape, and reshape the
nervous system, from the earliest stages of embryogenesis to death. There has been particular
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attention on miRNAs in the context of mammalian nervous
system development. Smirnova et al. (2005) compared miRNAs
expression in embryonic neuron and astrocyte cultures,
and found miR-124, a brain-enriched miRNA, preferentially
expressed in neurons. miR-124 expression gradually increased
and accumulated in parallel to neuronal maturation (Smirnova
et al., 2005) during CNS development (Deo et al., 2006;
Krichevsky et al., 2006). Blocking miR-124 activity in mature
neurons leads selectively to increased levels of non-neuronal
transcripts (Conaco et al., 2006), while increasing miR-124
activity in non-neuronal HeLa cells showed a shift of expression
proﬁle toward that of neuronal phenotype (Lim et al., 2005).
Makeyev et al. (2007) demonstrated that miR-124 promoted this
shift by triggering brain-speciﬁc alternative pre-mRNA splicing.
In mouse embryonic development, miR-124 directly targets
polypyrimidine-tract-binding protein (PTBP) mRNA, which
encodes a global repressor of alternative pre-mRNA splicing
in non-neuronal cells (Makeyev et al., 2007). During neuronal
diﬀerentiation, miR-124 reduces PTBP levels, leading to the
transition from non-nervous system to nervous system speciﬁc
alternative splicing patterns. Interestingly, repression of PTBP
is suﬃcient to induce trans-diﬀerentiation of ﬁbroblasts into
functional neurons (Xue et al., 2013).
Moreover, microRNA-124 is a subventricular zone (SVZ)
neuronal fate determinant. The SVZ is the largest neurogenic
niche in the adult mammalian brain. Knockdown of endogenous
miR-124 maintained puriﬁed SVZ stem cells as dividing
precursors, whereas ectopic expression led to increased neuron
formation. Sox9 was demonstrated to be the physiological target
of miR-124 responsible for this role (Cheng et al., 2009; Akerblom
et al., 2012). Neurogenesis in embryonic neuroepithelial cells
in the spinal cord is also regulated by miR-124 and its target
Sox9 (Farrell et al., 2011). Several other targets of miR-124
have been identiﬁed in mediating the process of neurogenesis.
For example, miR-124 in SVZ progenitor cells mediates stroke-
induced neurogenesis by targeting the JAG-Notch signaling
pathway in adult rats (Liu et al., 2011b). miR-124 also ensures
the transition from neural progenitors to neurons by repressing
two endogenous targets, LAMC1 and ITGB1, which are highly
expressed by neural progenitors, but are repressed upon
neuronal diﬀerentiation in the chick embryos (Cao et al., 2007).
SCP1 down-regulation is another critical factor for inducing
neurogenesis during embryonic CNS development in both chick
and mouse embryos, and miR-124 contributes to this process
in part by down-regulating SCP1 expression (Visvanathan et al.,
2007).
Besides eﬀects on neuron fate, miR-124 also contributes to
the control of neurite outgrowth during neuronal diﬀerentiation
possibly by cytoskeleton regulation in mouse P19 cells (Yu
et al., 2008), and aﬀects dendritic diﬀerentiation by regulating
RhoG (Schumacher and Franke, 2013). Overexpression of miR-
124 could lead to reduced astrocytic lineage diﬀerentiation by
inhibiting STAT3 signaling (Krichevsky et al., 2006). miR-124 is
essential for hippocampal axogenesis and retinal cone survival, as
it represses Lhx2 translation in mice (Sanuki et al., 2011). In post-
mitotic neurons, miR-124 represses BAF53a, which is essential
for an evolutionarily conserved program of post-mitotic neural
development and dendritic morphogenesis in mouse embryos
(Yoo et al., 2009).
In general, miR-124 has been shown to promote cell
diﬀerentiation and repress cell proliferation. In neuroblasts,
miR-124 was highly expressed in cells at G0/G1 phase (Cheng
et al., 2009), which results in the repression of Cdk6, a
protein mediating cell-cycle progression from G0/G1 (Silber
et al., 2008). miR-124 is expressed from the beginning
of eye development in Xenopus, and has been shown to
repress cell proliferation in the optic cup. However, this
is not true during earlier development. It was recently
reported that miR-124 is both necessary and suﬃcient to
promote cell proliferation and repress neurogenesis at the optic
vesicle stage which precedes optic cup formation, showing
an anti-neural role by negatively regulating the expression
of the pro-neural marker NeuroD1, and revealing a novel
regulatory role of miR-124 in neural development (Liu et al.,
2011a).
miR-124 in Neurodegeneration
Memory storage and memory-related synaptic plasticity rely on
precise spatiotemporal regulation of gene expression. miR-124
plays a critical role in the regulation of signaling molecules
underlying synaptic plasticity and memory (Fischbach and
Carew, 2009). miR-124 was exclusively present presynaptically in
a sensory-motor synapse where it constrains serotonin-induced
synaptic facilitation through regulation of the transcriptional
factor CREB in Aplysia, suggesting a role for miR-124 in
long-term plasticity of synapses in the mature nervous system
(Rajasethupathy et al., 2009). miR-124 regulates cocaine-induced
plasticity by targeting BDNF in rats, which is well implicated
in synaptic plasticity and plays a central role in reward and
memory (Chandrasekar and Dreyer, 2009). Thus, miR-124 may
be involved in neurodegeneration diseases such as Alzheimer’s
disease (AD) and Parkinson’s disease (PD).
Alzheimer’s disease is an age-related chronic
neurodegenerative disease and the most prevalent type of
dementia in elderly people. miR-124 level is down-regulated
(human-originated, n = 5; Lukiw, 2007), while the expression
of β-site APP cleaving enzyme 1 (BACE1) is up-regulated, in
AD patients’ brain (Bigl et al., 2000; Sun et al., 2002; Yang et al.,
2003; Lukiw, 2007; Smith et al., 2011), indicating a possible
inverse relationship between them. Fang et al. (2012) further
demonstrated that miR-124 overexpression or knockdown could
decrease or increase the expression of BACE1, and found that
miR-124 may work as an important regulating factor to alleviate
cell death in the process of AD by targeting BACE1 in rat PC12
cells (Fang et al., 2012), which is considered to participate in the
rate-limiting step in the production of neurotoxic Aβ (Hebert
et al., 2008). Melatonin levels are decreased in the serum of AD
patients, and its supplementation is able to reverse AD pathology
and memory deﬁcits. Wang et al. (2013) demonstrated that
melatonin rescues the EPACs/miR-124/Egrl signaling pathway
in rats, which is important in learning and memory (Yang et al.,
2012).
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Non-coding miRNAs are necessary for the survival of post-
mitotic cells such as neurons that die in PD and other brain
diseases. Kim et al. (2007) showed that mice lacking Dicer in
speciﬁc dopamine neurons develop a progressive loss of neurons
later in life, displaying a Parkinson’s-like disease. Thus, miRNAs
are essential for maintaining dopaminergic neurons in the brain,
and participate in the pathogenesis of PD. Furthermore, a recent
review has shown that one–fourth (49 out of 202, MIRECORDS
database) of “validated” targets of miR-124 are de-regulated in PD
(Sonntag, 2010), indicating an important role for miR-124 in the
regulation of this disease.
miR-124 in CNS Stress
A number of miRNAs are shown to have important roles in the
regulation of stress responses, and indeed miRNAs are shown to
impart robustness to stress responses. The capacity of miRNAs
to inhibit 100s of transcripts that are activated by stress makes
them candidates for stabilizers of the homeostatic state of the
transcriptome (Manakov et al., 2012).
Mental stress modiﬁes both cholinergic neuro-transmission
and alternative splicing in the brain. Meerson et al. (2010)
reported that stress changes rat brain miRNA proﬁles detected
by microarray, and some of these stress-regulated miRNAs,
including miR-124, regulate alternative splicing. Also, miR-124 is
up-regulated in the rat hippocampus after acute immobilization
stress (Meerson et al., 2010). Another study examined the eﬀect
of maternal separation stress on miRNA expression and found
the miR-124 level is elevated in the prefrontal cortex of stressed
mice at P14 (Uchida et al., 2010). Paraventricular nucleus (PVN)
neurons are aﬀected by psychological stress through immune
response activation. However, miR-124 was not aﬀected by stress
in mouse PVN (Mckennirey, 2011). In vitro, miR-124 from
primary cultured neurons was signiﬁcantly increased in response
to all four neuronal challenge response sets (transfection, KCl,
kainite, aging; Manakov et al., 2012).
Hundreds of transcripts endogenously expressed in neurons
with target sites for miR-124 are coordinately upregulated
in a variety of neuronal stresses. Overexpression of miR-124
indeed signiﬁcantly inhibits expression of 100s of stress-induced
transcripts detected by microarray (Manakov et al., 2012).
Glucocorticoid and its receptor (glucocorticoid receptor, GR)
exert profound eﬀects on a variety of physiological processes,
including adaptation to stress. Acute or chronic stress decreased
GR mRNA in the PVN (Noguchi et al., 2010). Vreugdenhil et al.
(2009) found that miR-124 decreased GR protein level and GR-
mediated events. miR-124 expression also varies over time during
the stress hyporesponsive period, a neonatal period when GC
signaling is modulated (Vreugdenhil et al., 2009). By regulating
GRs, miR-124 can aﬀect a variety of systemic stress responses.
miR-124 in Neuroimmunity
MicroRNAs have unique expression proﬁles in cells of the
innate and adaptive immune systems and have pivotal roles
in the regulation of both cell development and function
(O’Connell et al., 2010). Soreq and Wolf (2011) designated
miRNAs which notably aﬀect both immune and neuronal
functions as NeurimmiRs. NeurimmiRs may act as ‘negotiators’
between the nervous and immune systems (Soreq and Wolf,
2011). The cholinergic anti-inﬂammatory pathway is a link
between the brain and the immune system of the host in
response to an immune challenge. This pathway controls the
inﬂammatory response through interaction with peripheral α7
subunit–containing nicotinic acetylcholine receptors (α7AChR)
expressed on macrophages (Pavlov et al., 2003). Our group found
miR-124 is necessary for the cholinergic anti-inﬂammatory action
by inhibiting the production of pro-inﬂammatory cytokines (Sun
et al., 2013b), and miR-124 may act as an NeurimmiRs.
The p38 mitogen-activated protein kinases (MAPKs)
are central regulatory nodes coordinating acute stress and
inﬂammatory responses. Lawson et al. (2013) reported that
expression of the p38α protein is suppressed in the brain by two
neuron-selective miRNAs, miR-124, and -128. miR-124 may
inﬂuence neuroimmunity by aﬀecting p38α -mediated signaling.
Microglial cells are macrophages that are resident in the
brain and spinal cord and form the frontline defense of the
innate immune system. Utilizing a mouse model of multiple
sclerosis (MS) and experimental autoimmune encephalomyelitis
(EAE), Ponomarev et al. (2011) showed that microglia miR-124
expression decreased by ∼70% during the course of the disease,
while overexpression of miR-124 could promote microglia
quiescence and suppress EAE by deactivating macrophages via
the C/EBP-α-PU.1 pathway (Zhang et al., 2004). Treatment of
mice with miR-124 at the onset of EAE substantially ameliorated
clinical symptoms and enhanced recovery in mice (Ponomarev
et al., 2011).
The ability to prevent and attenuate EAE has implications
for miR-124 in the treatment of neurodegenerative diseases such
as MS and AD, where microglial cells are thought to play an
integral role in the inﬂammatory process (Conrad and Dittel,
2011). Studies have already documented inﬂammation in AD,
PD, amyotrophic lateral sclerosis (ALS), MS, and a growing
number of other nervous system pathologies (Glass et al., 2010).
However, a major question is whether pharmacological inhibition
of inﬂammation pathways will be able to safely reverse or slow the
course of disease, which needs further investigation.
miR-124 in Stroke
PlasmamiRNAs have been investigated as biomarkers for various
diseases, including stroke. Recently, microarray analyses were
done to characterize the miRNA expression proﬁle in various
stroke models (Jeyaseelan et al., 2008; Dharap et al., 2009; Liu
et al., 2010; Yuan et al., 2010; Weng et al., 2011). The abundance
of miR-124 in the CNS has accelerated eﬀorts to determine if it
can be used as an eﬀective stroke treatment.
Jeyaseelan et al. (2008) ﬁrst reported an elevated level of miR-
124 in the brain samples from rats with middle cerebral artery
occlusion (MCAO) followed by 24 h reperfusion. One of its
predicted targets, the VSNL1 gene, which is a neuronal calcium
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TABLE 1 | Targets of microRNA-124 (miR-124) in central nervous system (CNS).
Target gene name Abbreviation CNS disorder Function in CNS
SRY-box transcription
factor
Sox9 Neurogenesis Neurogenesis in embryonic neuroepithelial cells in the spinal cord is regulated
by miR-124 and its target Sox9 (Farrell et al., 2011).
Small C-terminal domain
phosphatase 1
SCP1 Neurogenesis
glioblastoma
SCP1 down-regulation induces neurogenensis, and miR-124 contributes to
this process in part by targeting it (Visvanathan et al., 2007).
miR-124 controls self-renewal and tumorigenic competence of human
glioblastoma cells by targeting SCP1 and PTPN12 phosphatases (Lee et al.,
2013).
LIM homeobox protein 2 Lhx2 Neurogenesis Lhx2 is required for hippocampal formation, and miR-124 is essential for
hippocampal axogenesis and retinal cone survival by repressing Lhx2
translation (Sanuki et al., 2011).
Jagged-1 JAG1 Neurogenesis miR-124 targets JAG1/Notch signaling pathway to inhibit neurogenesis (Liu
et al., 2011b).
ephrin-B1 EfnB1 Neurogenesis EfnB1 is a target of miR-124 in neurogenesis, while miR-124 is itself regulated
by EfnB1 in neural progenitor cells (Arvanitis et al., 2010).
Distal-less homeobox 2 DLX2 Neurogenesis DLX2 is a miR-124 target and regulates generation of interneurons in the
embryo and promotes neurogenesis (Liu et al., 2011b).
Synaptogyrin 2 Syngr2 Neuronal
differentiation
SYNGR2 is down-regulated by miR-124 and is a non-neural paralogue of the
neural-specific gene synaptogyrin 1 (Lim et al., 2005).
BRG1/brm-associated factor 53a Baf53a Neuronal
differentiation
In post-mitotic neurons, miR-124 represses BAF53a, which is essential for an
evolutionarily conserved program of post-mitotic neural development and
dendritic morphogenesis (Yoo et al., 2009).
BRG1/brm-associated factor 45a Baf45a Neuronal
differentiation
miR-124 inhibits neural progenitor cell specific BAF45a to reduce proliferation
and induce differentiation (Yoo et al., 2009).
Polypyrimidine-tract-
-binding protein 1
PTBP1 Neuronal
differentiation
During neuronal differentiation, miR-124 reduces PTBP levels, leading to the
transition from non-nervous system to nervous system -specific alternative
splicing patterns (Makeyev et al., 2007).
Signal transducer and activator of
transcription 3
STAT3 Neuronal
differentiation
STAT3 selectively enhances differentiation of neural precursors along a glial
lineage. Overexpression of miR-124 could lead to the reduced astrocytic
lineage differentiation by inhibiting STAT3 signaling (Krichevsky et al., 2006).
Laminin γ1 LAMC1 Neuronal
differentiation
miR-124 ensures the transition from neural progenitors to neurons by
repressing LAMC1, which is highly expressed by neural progenitors,
contributing to the formation of basal laminae (Cao et al., 2007).
Integrin β1 ITGB1 Neuronal
differentiation
miR-124 ensures the transition from neural progenitors to neurons by
repressing ITGB1, which is highly expressed by neural progenitors,
maintaining the structural integrity of basal laminae (Cao et al., 2007).
Neurogenic differentiation 1 NeuroD1 Neuronal
differentiation
miR-124 shows an anti-neural role by negatively regulating the expression of
the pro-neural marker NeuroD1 at the optic vesicle stage (Liu et al., 2011a).
Ras homology growth-related RhoG Neuronal
differentiation
miR-124 inhibits RhoG expression and promotes axonal and dendritic
branching (Schumacher and Franke, 2013).
cAMP responsive element binding
protein
CREB Synaptic plasticity miR-124 constrains serotonin-induced synaptic facilitation through regulation
of the transcriptional factor CREB, which is an activator of transcription
required for long-term facilitation (Rajasethupathy et al., 2009).
Brain derived neurotropic factor BDNF Synaptic plasticity miR-124 regulates cocaine-induced plasticity by targeting BDNF, which is
implicated in synaptic plasticity and plays a central role in reward and memory
(Chandrasekar and Dreyer, 2009).
β-site APP cleaving enzyme 1 BACE1 Neurodegeneration miR-124 may work as an important regulating factor to alleviate cell death in
the process of AD by targeting BACE1, which is considered to participate the
rate-limiting step in the production of neurotoxic Aβ (Fang et al., 2012).
Glucocorticoid receptor GR Neuronal stress miR-124 is a down-regulator of GR activity with a possible relevance for brain
GC signaling (Vreugdenhil et al., 2009).
CCAAT/enhancer-binding protein-α C/EBP-α Neuroimmunity Overexpression of miR-124 could promote microglia quiescence and
suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1
pathway (Zhang et al., 2004; Ponomarev et al., 2011).
p38α mitogen-activated protein
kinases (MAPKs)
p38αMAPK Neuroimmunity miR-124 may influence neuroimmunity by affecting p38α -mediated signaling,
which are central regulatory nodes coordinating acute stress and
inflammatory responses (Lawson et al., 2013).
Visinin-like 1 Vsnl1 Stroke miR-124 level is elevated in the brain samples with MCAO followed by 24 h
reperfusion, which is correlated with the repression of VSNL1 gene, a
(Continued)
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TABLE 1 | Continued
Target gene name Abbreviation CNS disorder Function in CNS
neuronal calcium sensor protein identified as a specific and promising
biomarker in the plasma of stroke patients (Jeyaseelan et al., 2008).
Ubiquitin specific peptidase 14 Usp14 Stroke miR-124 targets USP14 to suppresses deubiquitination of REST, which
contributes to reduced brain injury and functional impairment, enhanced
neurovascular remodeling, and increased angioneurogenesis 8 weeks
post-stroke in mice with MCAO (Doeppner et al., 2013).
Inhibitory member of the apoptosis
-stimulating proteins of p53 family
iASPP Stroke Inhibition of miR-124 effectively reduced the ischemic injury due to the
up-regulation of iASPP level (Liu et al., 2013).
X-ray repair cross-complementing
protein 6
Ku70 Stroke Knockdown of cerebral miR-124 reduced cell death and infarct size, and
improved neurological outcomes by negatively regulating Ku70, which is
mainly involved in NHEJ of DSBs, V(D)J recombination, telomere
maintenance, and regulation of Bax-mediated apoptosis (Zhu et al., 2014).
Protein tyrosine phosphatase,
non-receptor type 12
PTPN12 Glioblastoma miR-124 controls self-renewal and tumorigenic competence of human
glioblastoma cells by targeting PTPN12 phosphatases (Conti et al., 2012; Lee
et al., 2013).
TEA domain family member 1 TEAD1 Glioblastoma miR-124 affects the ability of tumor cells to survive under O2 and/or nutrient
deprivation in part by directly regulating TEAD1, which is among factors
involved in cell proliferation and survival under stress (Mucaj et al., 2014).
Stress-associated endoplasmic
reticulum protein 1
SERP1 Glioblastoma miR-124 affects the ability of tumor cells to survive under O2 and/or nutrient
deprivation in part by directly regulating SERP1, which is among factors
involved in cell proliferation and survival under stress (Mucaj et al., 2014).
Neuroblastoma RAS viral (v-ras)
oncogene homolog
NRAS Glioblastoma NRAS is among the oncogene targets of miR-124 in glioblastoma and its
signaling pathway plays a crucial role in many cancers by regulating cell
proliferation, differentiation, and survival (Lang et al., 2012).
Pim-3 proto-oncogene PIM3 Glioblastoma PIM3 is among the oncogene targets of miR-124 in glioblastoma and it
promotes tumor cell growth through modulating cell cycle (Lang et al., 2012).
Rho-associated coiled-coil
containing
protein kinase 1
ROCK1 Glioma miR-124 inhibits glioma cells migration and invasion by down-regulation of
ROCK1, a well-known cell mobility-related gene (An et al., 2013).
Snail family zinc finger 2 SNAI2 Glioma miR-124 suppresses SNAI2 to inhibit glioma invasiveness and induce glioma
differentiation (Xia et al., 2012; Xie et al., 2012).
Twist family Twist Glioma miR-124 induces glioma differentiation by suppressing Twist (Xie et al., 2012).
Aryl hydrocarbon receptor (AHR) AHR Neuroblastoma miR-124 plays a pivotal role in neuroblastoma by targeting AHR, which may
promote neuroblastoma cell differentiation (Huang et al., 2011).
Solute carrier family 16, member 1 Slc16a1 Medulloblastoma SLC16A1 represents one of the non-neuronal targets regulated by miR-124,
and its enhanced expression in medulloblastoma may confer growth
advantage to tumor cells (Li et al., 2009).
Cyclin-dependent kinase 6 Cdk6 Medulloblastoma Cdk6 mediates cell-cycle progression from G0/G1 (Silber et al., 2008).
sensor protein identiﬁed as a speciﬁc and promising plasma
biomarker of stroke patients (Laterza et al., 2006), was decreased
in parallel with the increased miR-124 under the same conditions
(Jeyaseelan et al., 2008). Our previous study found miR-124 is
signiﬁcantly increased in ischemic penumbra as compared with
that in the non-ischemic area in MCAO mice. Accordingly,
brain tissues from stroke-prone spontaneously hypertensive rats
(SHR-SP) showed higher miR-124 levels than in spontaneously
hypertensive rats (SHRs; Sun et al., 2013a). Markedly increased
plasma miR-124 was also observed at 24 h after stroke for
both transient and permanent occlusions in rats (Laterza et al.,
2009; Weng et al., 2011). Consistently, miR-124 was predicted to
suppress acetylcholinesterase (AChE; Nadorp and Soreq, 2014),
whose plasma level was reduced in patients post ischemic stroke
(Ben Assayag et al., 2010), indicating a physiological relevance
between miR-124 and AChE. The above suggests that plasma
miR-124 released from the infracted brain may be a promising
candidate biomarker for stroke identiﬁcation.
Although there is no correlation between the infarct size and
plasma miR-124 level in rats after MCAO introduction (Weng
et al., 2011), eﬀorts have been made to explore whether miR-
124 treatment is eﬀective in stroke. Doeppner et al. (2013)
showed that exogenous miR-124 reduced brain injury and
functional impairment, enhanced neurovascular remodeling,
and increased angioneurogenesis 8 weeks post-stroke in mice
with MCAO, which is possible via the pathway involving
Usp14-dependent REST degradation. Similarly, our previous
study showed that miR-124 overexpression decreased the infarct
area of MCAO mice (Sun et al., 2013a). The anti-apoptosis
proteins Bcl-2 and Bcl-xL, key regulators in attenuating stroke-
induced apoptotic cell death (Martinou et al., 1994; Wiessner
et al., 1999; Graham et al., 2000), are found to be the
targets of miR-124 in this protective role for stroke. miR-
124 was also found to inhibit stroke-induced neurogenesis
by targeting the JAG1/Notch signaling pathway (Liu et al.,
2011b).
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However, conﬂicting miR-124 stroke therapy results have
also been reported. For example, Zhu et al. (2014) showed
that knockdown of cerebral miR-124 reduced cell death and
infarct size, and improved neurological outcomes by negatively
regulating Ku70. Additionally, Liu et al. (2013) found that
although a miR-124 mimic did not aﬀect the infarct volume at
24 h after ischemia, inhibition of miR-124 eﬀectively reduced
the ischemic injury due to iASPP expression up-regulation.
Therefore, the use of miR-124 as an eﬀective stroke treatment
necessitates further research.
miR-124 in Brain Tumor
Distinct patterns of miR-124 expression have been observed
in many cancers including glioblastomas (Silber et al., 2008).
miR-124 expression is signiﬁcantly decreased in anaplastic
astrocytoma and glioblastoma relative in human patients to non-
neoplastic brain tissue (Fowler et al., 2011; Hua et al., 2012;
Lang et al., 2012; Ho et al., 2013), and is expressed at diﬀerent
levels in glioblastoma compared with normal brain (Silber
et al., 2008; Godlewski et al., 2010). Overexpression of miR-
124 induced morphological changes and neural diﬀerentiation in
mouse neural stem cells and oligodendroglioma, accompanied by
reduced self-renewal and tumorigenicity (Silber et al., 2008). In
addition, the ectopic expression of miR-124 in a glioblastoma cell
line resulted in signiﬁcant inhibition of migration and invasion,
suggesting that miR-124 may be a novel inhibitor of glioblastoma
invasion (Fowler et al., 2011).
Several targets of miR-124 mediating this process have been
identiﬁed. It was reported that miR-124 controls self-renewal
and tumorigenic competence of human glioblastoma cells by
targeting SCP1 and PTPN12 phosphatases (Conti et al., 2012;
Lee et al., 2013). Xia et al. (2012) demonstrated that the
tumor suppressor activity of miR-124 could by partly due to its
inhibitory eﬀects on glioma stem – like traits and invasiveness
through down-regulation of SNAI2 in human. Others reported
that miR-124 inhibits glioma cells migration and invasion by
down-regulation of ROCK1 (An et al., 2013), and induced glioma
diﬀerentiation by suppressing Twist and SNAI2 (Xie et al., 2012).
A clinical investigation also showed a negative correlation
between miR-124 expression and a hypoxic gene signature
in glioblastoma patient samples. Increased miR-124 expression
aﬀects the ability of tumor cells to survive under O2 and/or
nutrient deprivation, while miR-124 re-expression increases
cell death in vivo and enhances the survival of mice bearing
intracranial xenograft tumors. miR-124 exerts this phenotype in
part by directly regulating TEAD1, MAPK14/p38α, and SERP1,
which are factors involved in cell proliferation and survival under
stress (Mucaj et al., 2014). Besides glioblastoma, neuroblastoma is
an embryonic tumor derived from the autonomic nervous system
neural-crest tissues, and is the most common extracranial solid
tumor in children. Huang et al. (2011) showed that miR-124 plays
a pivotal role in neuroblastoma by targeting aryl hydrocarbon
receptor (AHR), which may promote neuroblastoma cell
diﬀerentiation. These studies indicate that miR-124 is a potential
therapeutic target in brain tumor treatment.
Conclusion
We have discussed the importance of miR-124 in neuronal
development and function of the brain. Changes of miR-124
levels can serve as biomarkers that indicate the functional status
of a normal brain, as well as progression of CNS diseases.
Interestingly, it seems inverse eﬀect of miR-124 in tumorogenic
events and neurodegenerative processes. For example, miR-124
alleviates cell death in the process of AD by targeting BACE1,
while increases cell death in glioblastoma by regulating TEAD1,
MAPK14/p38α, and SERP1 (Mucaj et al., 2014). This might be
relevant to diﬀerent targets involved depending on the context
of diseases, cells and surroundings. Moreover, its regulation
of numerous targets (summarized in Table 1) classiﬁes it as
a suitable treatment for the complexity of pathophysiological
events launched by multifactorial CNS diseases, which require
therapies that are able to trigger a large set of orchestrated genes.
Therefore, we believe miR-124 and other miRNAs that fulﬁll this
criterion will replace single gene therapies for the treatment of
these kinds of diseases in the near future.
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